Insilico Medicine’s rentosertib shows potential to slow aging in landmark Phase III trial
Rentosertib's success could revolutionize aging treatment, influencing therapies for numerous age-related diseases beyond lung conditions.
The post Insilico Medicine’s rentosertib shows potential to slow aging in landmark Phase III trial appeared first on Crypto Briefing.
This content is automatically aggregated. Full credit goes to the original publisher (cryptobriefing.com).
